Decapeptyl Sustained Release 11.25 mg inj. susp. (pwdr. + solv.) s.c./i.m. amp. vial
Country: Belgium
Language: English
Source: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
Triptorelin Pamoate - Eq. Triptorelin 11,25 mg
Available from:
Ipsen SA-NV
ATC code:
L02AE04
INN (International Name):
Triptorelin Pamoate
Dosage:
11,25 mg
Pharmaceutical form:
Powder and solvent for suspension for injection
Composition:
Triptorelin Pamoate
Administration route:
Intramuscular use; Subcutaneous use
Therapeutic area:
Triptorelin
Product summary:
CTI code: 192516-01 - Pack size: 11.25 mg + 2 ml + 1 x Injection syringe + 3 x Injection needle - Commercialisation status: YES - FMD code: 03582186002735 - CNK code: 1428143 - Delivery mode: Medical prescription
Authorization status:
Commercialised: Yes
Authorization date:
1998-06-08
